RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 11, 2026, 10:02Hind Hanani: Understanding the Use of Antiphospholipid Syndrome Guidelines Worldwide
-
Jan 11, 2026, 09:56Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
-
Jan 11, 2026, 09:52Jamie Agunsday: Understanding Pregnancy-Related Deaths
-
Jan 11, 2026, 09:48Heghine Khachatryan: Rethinking First-Line Therapy for Iron Deficiency Anemia in Women
-
Jan 11, 2026, 09:44AdhesioRT Test Models Endometrial Receptivity to Optimize Implantation Timing – RBMO
-
Jan 11, 2026, 09:21ACOG Announces Maternal Health Awareness Day 2026 Webinar
-
Jan 11, 2026, 06:59John Cush: Subcutaneous Anifrolumab Effective in Lupus
-
Jan 10, 2026, 06:50Owen Xian Wen Tan: New Insights on β2-Glycoprotein I in Thrombosis Regulation
-
Jan 10, 2026, 06:35John Cush: Assess Reproductive Health in SLE Clinic Visits